
Transforming a Small Biopharma through Strategic Growth and Partnership Development
OBJECTIVE
Develop and expand an internal advocacy department to support both national and global rare disease communities.
Imara, Inc.

The Challenge
Imara, Inc., a biopharma company, aimed to strengthen its patient advocacy efforts and expand its global impact. With $63MM in Series B Financing secured, the challenge was clear: build a robust advocacy department to foster education, awareness, and access to clinical trials for rare blood disorders, while connecting meaningfully with underserved communities.
The Solution
The Hills Tandem (THT) partnered with Imara to transform its advocacy efforts and amplify its mission of supporting rare disease communities.
Strategic Advocacy Consultancy: Provided a clear roadmap for building and refining an impactful advocacy department to achieve long-term goals.
Community Access & Awareness: Fostered stronger relationships with global community groups to expand Imara’s reach and influence.
Tailored Communication Strategies: Developed culturally nuanced messaging to effectively engage with diverse audiences and enhance awareness.
Key Results
• 75+ Global Connections: Built meaningful partnerships with community groups across the globe.
• 50% Increase in Opportunities: Boosted conference sponsorships and speaking engagements, solidifying Imara’s position as an industry leader.
• 40,000+ Families Impacted: Directly supported families and individuals within the rare disease community, creating lasting change.
The Impact
Imara’s advocacy department now stands as a benchmark in the biopharma industry, exemplifying how patient-centered strategies can drive awareness, accessibility, and meaningful partnerships. Together, we’ve set the gold standard for rare disease advocacy and patient engagement.

More Client Stories
Explore the transformative journeys we’ve shared with our clients—delivering tailored solutions that inspire progress and lasting impact.